115 related articles for article (PubMed ID: 2428021)
1. Concentrations of androgens in human benign prostatic hypertrophic tissues incubated for up to three days.
Bolton NJ; Lukkarinen O; Vihko R
Prostate; 1986; 9(2):159-67. PubMed ID: 2428021
[TBL] [Abstract][Full Text] [Related]
2. Androgens and prostate-specific acid phosphatase in whole tissue and in separated epithelium from human benign prostatic hypertrophic glands.
Bolton NJ; Lahtonen R; Vihko P; Kontturi M; Vihko R
Prostate; 1981; 2(4):409-16. PubMed ID: 6173873
[TBL] [Abstract][Full Text] [Related]
3. Endogenous steroid levels in the human prostate from birth to old age: a comparison of normal and diseased tissues.
Hammond GL
J Endocrinol; 1978 Jul; 78(1):7-19. PubMed ID: 79632
[TBL] [Abstract][Full Text] [Related]
4. Androgen concentrations in epithelial and stromal cell nuclei of human benign prostatic hypertrophic tissues.
Lahtonen R; Bolton NJ; Lukkarinen O; Vihko R
J Endocrinol; 1983 Dec; 99(3):409-14. PubMed ID: 6196427
[TBL] [Abstract][Full Text] [Related]
5. Relationships between oestradiol-17 beta, testosterone, dihydrotestosterone and 5 alpha-androstane-3 alpha, 27 beta-diol in human benign hypertrophy and carcinoma of the prostate.
Ghanadian R; Puah CM
J Endocrinol; 1981 Feb; 88(2):255-62. PubMed ID: 6162906
[TBL] [Abstract][Full Text] [Related]
6. Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate.
Habib FK; Lee IR; Stitch SR; Smith PH
J Endocrinol; 1976 Oct; 71(1):99-107. PubMed ID: 62008
[TBL] [Abstract][Full Text] [Related]
7. [Endogenous androgen levels of human prostatic tissues].
Morioka M; Takeda K; Mitsuhata N; Ohashi T; Ohmori H; Saito T; Kanbegawa A
Nihon Naibunpi Gakkai Zasshi; 1982 Jul; 58(7):876-85. PubMed ID: 6182032
[TBL] [Abstract][Full Text] [Related]
8. Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: effects on tissue androgen concentration, 5 alpha-reductase activity and androgen receptor content.
Forti G; Salerno R; Moneti G; Zoppi S; Fiorelli G; Marinoni T; Natali A; Costantini A; Serio M; Martini L
J Clin Endocrinol Metab; 1989 Feb; 68(2):461-8. PubMed ID: 2465302
[TBL] [Abstract][Full Text] [Related]
9. Distribution and concentrations of androgens in epithelial and stromal compartments of the human benign hypertrophic prostate.
Bolton NJ; Lahtonen R; Hammond GL; Vihko R
J Endocrinol; 1981 Jul; 90(1):125-31. PubMed ID: 6167652
[TBL] [Abstract][Full Text] [Related]
10. Subnormal tissue 3 alpha-androstanediol and androsterone in prostatic hyperplasia.
Meikle AW; Stringham JD; Olsen DC
J Clin Endocrinol Metab; 1978 Oct; 47(4):909-13. PubMed ID: 95628
[TBL] [Abstract][Full Text] [Related]
11. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
Monti S; Di Silverio F; Iraci R; Martini C; Lanzara S; Falasca P; Poggi M; Stigliano A; Sciarra F; Toscano V
J Clin Endocrinol Metab; 2001 Apr; 86(4):1700-6. PubMed ID: 11297606
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
Habib FK; Ross M; Tate R; Chisholm GD
Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
[TBL] [Abstract][Full Text] [Related]
13. A method for tissue extraction and determination of prostate concentrations of endogenous androgens by radioimmunoassay.
Albert J; Geller J; Geller S; Lopez D
J Immunol Methods; 1976; 12(3-4):303-21. PubMed ID: 965729
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia.
Cochran RC; Ewing LL; Niswender GD
Invest Urol; 1981 Nov; 19(3):142-7. PubMed ID: 6170603
[TBL] [Abstract][Full Text] [Related]
15. Determination of testosterone and its tissue metabolites (DHT and 3 alpha-diol) in human plasma and prostatic tissue by isotopic dilution mass spectrometry.
Moneti G; Giovannini MG; Guarna A; Forti G; Salerno R; Magini A; Serio M
J Steroid Biochem; 1987; 27(1-3):53-9. PubMed ID: 2447389
[TBL] [Abstract][Full Text] [Related]
16. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
Krieg M; Bartsch W; Thomsen M; Voigt KD
J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
[TBL] [Abstract][Full Text] [Related]
17. Decreased urinary 5 alpha-androstane-3 alpha,17 beta-diol glucuronide excretion in patients with benign prostatic hyperplasia.
Wright F; Poizat R; Bongini M; Bozzolan F; Doukani A; Mauvais-Jarvis P
J Clin Endocrinol Metab; 1985 Feb; 60(2):294-8. PubMed ID: 2578133
[TBL] [Abstract][Full Text] [Related]
18. New approaches for the treatment of prostatic hypertrophy and cancer.
Zoppi S; Cocconi M; Serio M; Martini L; Motta M
Horm Res; 1987; 28(2-4):250-60. PubMed ID: 2456974
[TBL] [Abstract][Full Text] [Related]
19. Tissue androgen concentrations in golden hamsters with benign prostatic tumours.
Finney RW; Harper ME; Gaskell SJ; Griffiths K
J Endocrinol; 1980 Mar; 84(3):353-61. PubMed ID: 6156223
[TBL] [Abstract][Full Text] [Related]
20. Endogenous androgen levels in epithelium and stroma of human benign prostatic hyperplasia and normal prostate.
Bartsch W; Krieg M; Becker H; Mohrmann J; Voigt KD
Acta Endocrinol (Copenh); 1982 Aug; 100(4):634-40. PubMed ID: 6181638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
